Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies.

Samanta, Joydeep; Mishra, Debashish; Chattopadhyay, Arghya; Dhir, Varun

Samanta, Joydeep; Mishra, Debashish; Chattopadhyay, Arghya; Dhir, Varun.

Afiliación

Samanta J; Department of Internal Medicine, Clinical Immunology and Rheumatology Unit, Post Graduate Institute of Medical Education and Research, Chandigarh, Punjab, India.
Mishra D; Department of Internal Medicine, Clinical Immunology and Rheumatology Unit, Post Graduate Institute of Medical Education and Research, Chandigarh, Punjab, India.
Chattopadhyay A; Department of Internal Medicine, Clinical Immunology and Rheumatology Unit, Post Graduate Institute of Medical Education and Research, Chandigarh, Punjab, India.
Dhir V; Department of Internal Medicine, Clinical Immunology and Rheumatology Unit, Post Graduate Institute of Medical Education and Research, Chandigarh, Punjab, India.

Rheumatology (Oxford) ; 60(3): e109, 2021 03 02.

Article en En | MEDLINE | ID: mdl-32910815

Asunto(s)

Anticuerpos Antifosfolípidos; Síndrome Antifosfolípido; Algoritmos; Síndrome Antifosfolípido/tratamiento farmacológico; Femenino; Humanos; Embarazo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome Antifosfolípido / Anticuerpos Antifosfolípidos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google